Bragar Eagel & Squire, PC investigates Corcept, RBB and Verra and encourages… | News

NEW YORK, May 06, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is investigating potential claims against Corcept Therapeutics, Inc. (NASDAQ : CORT), RBB Bancorp (NASDAQ: RBB) and Verra Mobility Corp. (NASDAQ: VRRM). Our investigations focus on whether these companies have violated federal securities laws and/or engaged in other illegal business practices. Additional information on each case can be found at the link provided.

Corcept Therapeutics, Inc. (NASDAQ: CORT)

On December 8, 2021, Corcept disclosed in a filing with the United States Securities and Exchange Commission that “[o]On November 15, 2021, the Company received a subpoena from the United States Attorney’s Office for the District of New Jersey (the “NJ USAO”) pursuant to Section 248 of the Portability and Accountability Act of 1996. (HIPAA) requesting information regarding the sale and promotion of Korlym, Corcept’s relationships and payments with healthcare professionals who may prescribe or recommend Korlym, and prior authorization and reimbursement of Korlym. Corcept further revealed that “[t]The NJ USAO has notified Corcept that it is investigating whether any criminal or civil violations by Corcept have occurred in connection with the matters referenced in the subpoena.

On this news, Corcept’s stock price fell $3.71 per share, or 16.91%, to close at $18.23 per share on December 8, 2021.

For more information on the Corcept survey, visit:


On February 18, 2022, RBB Bancorp announced the abrupt departure of Tammy Song, Executive Vice President and Chief Loan Officer of RBB Bancorp’s wholly owned subsidiary, Royal Business Bank.

Four days later, on February 22, 2022, RBB Bancorp announced that its Chairman and Chief Executive Officer (Alan Thian) would take a leave of absence, effective immediately, pending an internal investigation by a special board committee. of administration of the company.

On this news, RBB Bancorp’s stock price fell $2.69 per share, or about 10.45%, from $25.75 to $23.06 over two trading days.

For more information on RBB Bancorp’s investigation, visit:

Verra Mobility Corp. (NASDAQ: VRRM)

On February 28, 2022, Verra Mobility announced that it had filed a late filing notice with the SEC, as it will be unable to file its Form 10-K for the fiscal year ended December 31, 2021 as of the date due March 1. 2022, and the Company should not do so within the permitted extension period of 15 days.

Additionally, Verra Mobility announced that “[d]During its review process of the 2021 year-end financial statements, Verra Mobility. . . determined that the revenues of the company’s recently acquired Australian subsidiary, Redflex Holdings Limited, may not have been accounted for in accordance with generally accepted accounting principles. The Company’s Audit Committee is investigating the circumstances surrounding these issues to determine, among other things, whether a related adjustment is required for the previously issued financial statements for the second and third quarters of fiscal 2021.”

On this news, Verra Mobility stock fell 7.6% in intraday trading on February 28, 2022, hurting investors.

For more information on the Verra survey, visit:

About Bragar Eagel & Squire, PC:

Bragar Eagel & Squire, PC is a nationally recognized law firm with offices in New York, California and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivatives and other complex litigation before state and federal courts across the country. For more information about the company, please visit Lawyer advertisement. Prior results do not guarantee similar results.

Contact information:

Bragar Eagel & Squire, CP Brandon Walker, Esq. Alexandra B. Raymond, Esq. (212) 355-4648

Copyright 2022 GlobeNewswire, Inc.

Comments are closed.